PrintCombination Oral Medicines
Brand Name (Generic Name)
Actoplus Met (pioglitazone metformin)
Warning: pioglitazone, which is a component of Actoplus Met, may be associated with an increased risk of bladder cancer in some patients after using Actos for more than one year. For more information on side effects, refer to the pioglitazone and metformin sections.
Avandamet (rosiglitazone maleate metformin hydrochloride)
Warning: rosiglitazone, which is a component of Avandamet, can cause or worsen congestive heart failure in some patients. Due to the side effects, Avandamet is now only available to patients who enroll in a special program. Talk to your doctor to get more information on the program. For more information on side effects, refer to the rosiglitazone and metformin sections.
Avandaryl (rosiglitazone glimepiride)
Duetact (pioglitazone glimepiride)
Glucovance (glyburide metformin hydrochloride)
For more information on side effects, refer to the glyburide and metformin sections.
Janumet (sitagliptin/metformin HCl)
For more information on side effects, see DPP-IV Inhibitors and biguanides.
Janumet XR (sitagliptin (Januvia) and metformin hydrochloride (HCl) extended-release) is a once-daily oral medication. For more information on side effects, see DPP-IV Inhibitors and biguanides.
Jentadueto (linagliptin/metformin hydrochloride) is a twice-daily oral medication.
For more information on side effects, see DPP-IV Inhibitors and biguanides.
Juvisync (sitagliptin and simvastatin)
For more information on side effects, see DPP-IV Inhibitors and Simvastatin.
Kazano (alogliptin/metformin)
Kombiglyze XR (saxagliptin/metformin)
Once-a-day metformin extended-release (XR) plus saxagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor combination tablet. For more information, see DPP-IV Inhibitors and biguanides
Metaglip (glipizide metformin)
Oseni (alogliptin/pioglitazone)
PrandiMet (repaglinide metformin HCl tablets)
A meglitinides and biguanides combination drug approved for use as an adjunct to diet and exercise in type 2 diabetes patients when response to repaglinide or metformin monotherapy is inadequate.
Reviewed by James A. Bennett 5/13
You are subscribed!
You are subscribed!
You are subscribed!
Recipe Shuffle
I'm sitting waiting for a table at the cafe' for me and a friend who is running a bit late. Feeling a little off, I grab my test kit and poke my finger, getting a little blood droplet. "Does that hurt?" Asks the man sitting next to me. He's an older guy, with some pretty profound ear hair. I note the ear hair as I say "Sort of... I think I'm kind of used to it now. I've been doing it a long time." My sugar is a little elevated...
